146 related articles for article (PubMed ID: 11479401)
21. Usefulness of fecal calprotectin determination in pediatric intestinal diseases.
Rosso C; Caviglia GP; Pellicano R
Minerva Pediatr; 2016 Dec; 68(6):478-486. PubMed ID: 27668453
[TBL] [Abstract][Full Text] [Related]
22. Limited value of fecal calprotectin in patients with liver cirrhosis.
Burri E; Manz M; Rieder S; Beglinger C
Scand J Gastroenterol; 2011 Dec; 46(12):1527-8. PubMed ID: 21905979
[No Abstract] [Full Text] [Related]
23. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.
Konikoff MR; Denson LA
Inflamm Bowel Dis; 2006 Jun; 12(6):524-34. PubMed ID: 16775498
[TBL] [Abstract][Full Text] [Related]
24. [Faecal calprotectin : a useful tool for the primary care physician ?].
D'angelo F; Perrier A
Rev Med Suisse; 2016 Oct; 12(535):1752-1756. PubMed ID: 28692215
[TBL] [Abstract][Full Text] [Related]
25. [Research advances in the role of fecal calprotectin in intestinal development and diseases among children].
Li F; Sheng XY
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Oct; 16(10):1064-9. PubMed ID: 25344194
[TBL] [Abstract][Full Text] [Related]
26. Fecal calprotectin concentrations in alcoholic patients: a longitudinal study.
Montalto M; Gallo A; Ferrulli A; Visca D; Campobasso E; Cardone S; D'Onofrio F; Santoro L; Covino M; Mirijello A; Leggio L; Gasbarrini G; Addolorato G
Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):76-80. PubMed ID: 21030869
[TBL] [Abstract][Full Text] [Related]
27. Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever.
Gucenmez OA; Kume T; Makay B; Babayigit O; Arslan N; Unsal E
Int J Rheum Dis; 2018 Oct; 21(10):1844-1848. PubMed ID: 30345692
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort.
Burri E; Manz M; Rothen C; Rossi L; Beglinger C; Lehmann FS
Clin Chim Acta; 2013 Feb; 416():41-7. PubMed ID: 23178549
[TBL] [Abstract][Full Text] [Related]
29. Predictive Value of Fecal Calprotectin in Pediatric Graft-Versus-Host Disease.
Wadhwani SI; Nakayuenyongsuk W; Shinn L; Chase P; Kharbanda S; Bass D; Park KT
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):e208-e209. PubMed ID: 27504814
[No Abstract] [Full Text] [Related]
30. Calprotectin and lactoferrin levels in the gingival crevicular fluid of children.
Miyasaki KT; Voganatsi A; Huynh T; Marcus M; Underwood S
J Periodontol; 1998 Aug; 69(8):879-83. PubMed ID: 9736370
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic accuracy of point-of-care fecal calprotectin and immunochemical occult blood tests for diagnosis of organic bowel disease in primary care: the Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) study.
Kok L; Elias SG; Witteman BJ; Goedhard JG; Muris JW; Moons KG; de Wit NJ
Clin Chem; 2012 Jun; 58(6):989-98. PubMed ID: 22407858
[TBL] [Abstract][Full Text] [Related]
32. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease.
Tibble JA; Sigthorsson G; Bridger S; Fagerhol MK; Bjarnason I
Gastroenterology; 2000 Jul; 119(1):15-22. PubMed ID: 10889150
[TBL] [Abstract][Full Text] [Related]
33. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.
Tibble J; Sigthorsson G; Foster R; Sherwood R; Fagerhol M; Bjarnason I
Gut; 2001 Sep; 49(3):402-8. PubMed ID: 11511563
[TBL] [Abstract][Full Text] [Related]
34. [FECAL NONINVASIVE TESTS (CALPROTECTIN, TRANSFERRIN, HEMOGLOBIN) IN COMPLEX DIAGNOSIS OF DISEASES OF INTESTINES].
Livzan MA; Lyalukova EA; Nechaeva G; Osipenko MF; Dolgih TI
Eksp Klin Gastroenterol; 2015; (3):34-8. PubMed ID: 26281175
[TBL] [Abstract][Full Text] [Related]
35. Faecal calprotectin in term and preterm neonates.
Kapel N; Campeotto F; Kalach N; Baldassare M; Butel MJ; Dupont C
J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):542-7. PubMed ID: 20818270
[TBL] [Abstract][Full Text] [Related]
36. Faecal calprotectin detects subclinical bowel inflammation and may predict treatment response in spondyloarthritis.
Østgård RD; Deleuran BW; Dam MY; Hansen IT; Jurik AG; Glerup H
Scand J Rheumatol; 2018 Jan; 47(1):48-55. PubMed ID: 28649913
[TBL] [Abstract][Full Text] [Related]
37. Calprotectin, a leukocyte protein related to inflammation, in gingival crevicular fluid.
Kido J; Nakamura T; Kido R; Ohishi K; Yamauchi N; Kataoka M; Nagata T
J Periodontal Res; 1998 Oct; 33(7):434-7. PubMed ID: 9842509
[No Abstract] [Full Text] [Related]
38. Fecal calprotectin concentration in patients with colorectal carcinoma.
Kristinsson J; Røseth A; Fagerhol MK; Aadland E; Schjønsby H; Børmer OP; Raknerud N; Nygaard K
Dis Colon Rectum; 1998 Mar; 41(3):316-21. PubMed ID: 9514426
[TBL] [Abstract][Full Text] [Related]
39. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
Fagerberg UL; Lööf L; Myrdal U; Hansson LO; Finkel Y
J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):450-5. PubMed ID: 15795593
[TBL] [Abstract][Full Text] [Related]
40. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
